Although semiconductors and other AI-related stocks continue to lift the broader market, investors may want to turn their attention to the medical sector.
Not to say it’s time to shift away from tech-heavy portfolios, but the essentiality of healthcare products and services may be desirable if energy prices remain elevated due to production disruptions in the Middle East.
On top of this, many medical stocks are making the case for undervaluation, and here are three that recently made their way onto the coveted Zacks Rank #1 (Strong Buy) list with appealing growth trajectories as well.
This post originally appeared at Zacks.